Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.11
$1.22
$0.84
$2.03
$42.32M0.99119,306 shs50,503 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Vroom, Inc. stock logo
VRM
Vroom
$11.63
+5.4%
$12.05
$8.11
$225.60
$20.82M1.93147,454 shs50,272 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.00%-3.48%-7.50%+2.78%-32.32%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Vroom, Inc. stock logo
VRM
Vroom
+5.44%+7.09%-10.88%-44.11%-82.65%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
1.4515 of 5 stars
3.50.00.00.00.03.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Vroom, Inc. stock logo
VRM
Vroom
0.1226 of 5 stars
0.03.00.00.00.90.80.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00530.63% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Vroom, Inc. stock logo
VRM
Vroom
N/AN/AN/AN/A

Current Analyst Ratings

Latest VRM, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.37N/AN/A$2.97 per share0.37
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Vroom, Inc. stock logo
VRM
Vroom
$893.20M0.02N/AN/A$68.19 per share0.17

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Vroom, Inc. stock logo
VRM
Vroom
-$365.54M-$209.31N/AN/A-40.92%-130.45%-22.97%5/14/2024 (Estimated)

Latest VRM, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
3/13/2024Q4 2023
Vroom, Inc. stock logo
VRM
Vroom
N/A-$80.51-$80.51-$80.51N/A$235.92 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Vroom, Inc. stock logo
VRM
Vroom
N/AN/AN/AN/AN/A

Latest VRM, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Vroom, Inc. stock logo
VRM
Vroom
3.72
1.11
0.92

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Vroom, Inc. stock logo
VRM
Vroom
25.79%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Vroom, Inc. stock logo
VRM
Vroom
1.38%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Vroom, Inc. stock logo
VRM
Vroom
1,6821.79 million1.77 millionNot Optionable

VRM, BOLT, CZX, and FCR Headlines

SourceHeadline
Vroom to Release First Quarter 2024 Earnings on May 9, 2024Vroom to Release First Quarter 2024 Earnings on May 9, 2024
businesswire.com - April 23 at 4:15 PM
CarMax: Is There a Silver Lining to the Earnings Car Wreck?  (VRM)CarMax: Is There a Silver Lining to the Earnings Car Wreck? (VRM)
marketbeat.com - April 22 at 8:55 AM
CarMax’s Earnings Reveal Market Headwinds (VRM)CarMax’s Earnings Reveal Market Headwinds (VRM)
nasdaq.com - April 12 at 7:00 AM
Vroom Delivery and Finix Team on Convenience Store PaymentsVroom Delivery and Finix Team on Convenience Store Payments
pymnts.com - April 8 at 5:01 PM
Vroom Completes Wind-Down of eCommerce, Used Vehicle Dealership BusinessesVroom Completes Wind-Down of eCommerce, Used Vehicle Dealership Businesses
pymnts.com - April 5 at 11:46 AM
Vroom winds down e-commerce and used vehicle dealership businessVroom winds down e-commerce and used vehicle dealership business
msn.com - April 5 at 10:29 AM
VRM Mar 2024 1.000 callVRM Mar 2024 1.000 call
ca.finance.yahoo.com - March 16 at 8:15 PM
VRM Mar 2024 1.000 put(CONTRACTVRM Mar 2024 1.000 put(CONTRACT
finance.yahoo.com - March 16 at 5:14 AM
Vroom: Q4 Earnings SnapshotVroom: Q4 Earnings Snapshot
finance.yahoo.com - March 13 at 8:08 PM
Vroom Reports Q4 Results, Sees E-Commerce Wind Down Complete By Q1 EndVroom Reports Q4 Results, Sees E-Commerce Wind Down Complete By Q1 End
msn.com - March 13 at 8:08 PM
Vroom Announces Fourth Quarter and Full Year 2023 ResultsVroom Announces Fourth Quarter and Full Year 2023 Results
finance.yahoo.com - March 13 at 8:08 PM
What Wall Street expects from Vrooms earningsWhat Wall Street expects from Vroom's earnings
markets.businessinsider.com - March 12 at 11:07 PM
Vroom (VRM) Price Target Increased by 7900.19% to 88.40Vroom (VRM) Price Target Increased by 7900.19% to 88.40
msn.com - February 24 at 9:17 AM
Why Is Vroom (VRM) Stock Up 25% Today?Why Is Vroom (VRM) Stock Up 25% Today?
investorplace.com - February 23 at 2:52 PM
Vroom to Release Fourth Quarter and Fiscal Year 2023 Earnings on March 13, 2024Vroom to Release Fourth Quarter and Fiscal Year 2023 Earnings on March 13, 2024
businesswire.com - February 22 at 4:15 PM
VRM Apr 2024 0.500 putVRM Apr 2024 0.500 put
finance.yahoo.com - February 21 at 1:47 PM
VRM Mar 2024 0.500 callVRM Mar 2024 0.500 call
finance.yahoo.com - February 20 at 10:38 PM
VRM Jul 2024 0.500 putVRM Jul 2024 0.500 put
finance.yahoo.com - February 20 at 10:38 PM
Vroom Stockholders Approve Reverse Split and Adjournment OptionVroom Stockholders Approve Reverse Split and Adjournment Option
msn.com - February 8 at 8:54 AM
Vroom Inc Announces 1-for-80 Reverse Stock SplitVroom Inc Announces 1-for-80 Reverse Stock Split
msn.com - February 8 at 8:54 AM
More details revealed about Vrooms wind down of e-commerce operationsMore details revealed about Vroom's wind down of e-commerce operations
bizjournals.com - February 5 at 6:21 PM
Insider Selling: Shortt Thomas H, Vroom Inc. [VRM] Chief Executive Officer divested 47,030 sharesInsider Selling: Shortt Thomas H, Vroom Inc. [VRM] Chief Executive Officer divested 47,030 shares
knoxdaily.com - February 3 at 7:57 AM
Vroom laying off 515 workers in Texas, part of nationwide restructuringVroom laying off 515 workers in Texas, part of nationwide restructuring
finance.yahoo.com - February 1 at 3:15 PM
The fall of a Carvana competitor left lost, disgruntled customers in the darkThe fall of a Carvana competitor left lost, disgruntled customers in the dark
msn.com - January 30 at 7:01 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Vroom logo

Vroom

NASDAQ:VRM
Vroom, Inc. operates as an automotive finance company. The company offers vehicle financing to its customers through third party dealers under the UACC brand. It also provides artificial intelligence powered analytics and digital services to dealers, automotive financial services companies, and others in the automotive industry for automotive retail. The company was formerly known as Auto America, Inc. and changed its name to Vroom, Inc. in July 2015. Vroom, Inc. was incorporated in 2012 and is based in Houston, Texas.